DNMT3A mutations are among the most frequent driver mutations in AML, third for frequencies to Fms-like tyrosine kinase 3 (FLT3) and nucleophosmin 1 (NPM1) [1]. This evidence concerns the gene NPM1 and acute myeloid leukemia.